Viewing Study NCT05738057


Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2026-04-23 @ 3:51 PM
Study NCT ID: NCT05738057
Status: RECRUITING
Last Update Posted: 2023-11-29
First Post: 2023-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Sponsor: Hua Li
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module